Clinical supply chains built for efficiency alone can become fragile when conditions change. Building resilience means knowing where flexibility matters before disruption hits.
- Undocumented Changes Break Validated Clinical Systems
- What Happens When The Clinical Forecast Changes?
- The Patient Is In The Room. Who Is Dispensing The IP?
- When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics
- AI Is Moving Clinical Supply From Forecasting To Real-Time Decision-Making
- One IP Receipt Problem Is An Exception. Four Is A Process.
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Your IP Shipment Arrives At 07:00. Who Opens The Box?
ON-DEMAND WEBINARS
Join Neta Bendelac from 4G Clinical and Limor Teomim from IMP CSS for an informative webinar as they explore how to mitigate the growing challenges faced as a result of the pandemic when it comes to DtP strategies and virtual trial design.
Gain insight into how a patient-centric approach to supply chain innovation in early phase development can accelerate your advanced therapy clinical trial programs.
Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1398569507 regulatory]( "5 Ways To Get Ready For IRT Regulatory Inspections")
5 Ways To Get Ready For IRT Regulatory InspectionsPreparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![Laptop clinical trials iStock-653839742]( "What Are Decentralized Clinical Trials (DCTs)?")
What Are Decentralized Clinical Trials (DCTs)?Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
![Digital supply chain mangement, global logistic-GettyImages-2250495598]( "Leveraging A Demand-Led Clinical Supply Model For Program-Level Product Pooling")
Leveraging A Demand-Led Clinical Supply Model For Program-Level Product PoolingSee how a global biopharmaceutical company was able to address inefficiencies and reduce waste within the clinical supply chain for a high-value therapy that faced strong demand but limited supply.
-
![iStock-1183744765-map]( "Managing Complex Global Drug Distribution And Expiry")
Managing Complex Global Drug Distribution And ExpiryA global top-ten pharma company sponsored a complex, 8-year Phase III trial across 43 countries. As costs mounted and supplies waned, it realized the trial could be better managed if outsourced.
-
![GettyImages-1078167682-brexit-uk-ireland-eu]( "Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain")
Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply ChainWith many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.
-
![GettyImages-1254705026 clinical supplies]( "Using Tech Enabled Solutions To Boost Productivity And Sustainability")
Using Tech Enabled Solutions To Boost Productivity And SustainabilityHow can investing in suitable tech solutions enhance efficiency and reduce companies' carbon footprint?
-
![pharma-spray-drying-GettyImages-1746637448]( "How CDMOs Deliver Precision and Scale in Pharma Spray Drying")
How CDMOs Deliver Precision and Scale in Pharma Spray DryingSpray drying depends on precise control, scalable methods, and solid quality systems. Strong design and GMP‑aligned execution help reduce risk and move complex compounds forward efficiently.
-
![GettyImages-1764818961 warehouse, storage, inventory]( "GxP Inventory Solution Delivers Real-Time Visibility, Operational Efficiency")
GxP Inventory Solution Delivers Real-Time Visibility, Operational EfficiencyExplore how unified forecasting and GxP-level inventory control can streamline your clinical supply chain, reduce risk, and strengthen oversight across every trial you run.
- Root Causes, Part 5: The Structural Changes Clinical Supply Needs
- Root Causes, Part 4: Why Clinical Supply Teams Are Always Firefighting
- Root Causes, Part 3: The Hidden Cost of Clinical Supply Work That Doesn't Move Trials Forward
- Root Causes, Part 2: The Translation Problem Behind Clinical Trial Execution
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
